SYDNEY, Jan. 30, 2026 /PRNewswire/ — SIA Booking Group Corporation (trading as EconomyBookings) acknowledges the Australian Competition and Consumer Commission’s (ACCC) infringement notices and allegations regarding aspects of how prices were displayed to consumers on our website in the Australian market. The company has paid penalties totalling A$39,600. The pricing display practice in question is […]
Category Archives: Pr Newswire
GUANGZHOU, China, Jan. 30, 2026 /PRNewswire/ — Youxin Technology Ltd (Nasdaq: YAAS) (the “Company” or “Youxin Technology”), a software as a service (“SaaS”) and platform as a service (“PaaS”) provider committed to helping retail enterprises digitally transform their businesses, today announced its financial results for the fiscal year ended September 30, 2025. Mr. Shaozhang Lin, Chief […]
EAST WINDSOR, N.J., Jan. 30, 2026 /PRNewswire/ — Greenland Technologies Holding Corporation (Nasdaq: GTEC) (“Greenland” or the “Company”), a technology developer and manufacturer of electric industrial vehicles and drivetrain systems for material handling machineries and vehicles, today announced the closing of its previously announced underwritten public offering of 5,083,330 units (the “Units”) at a public […]
NEW YORK, Jan. 30, 2026 /PRNewswire/ — OP Labs PBC (oplabs.co), a blockchain infrastructure provider that enables developers and enterprises to launch scalable, secure and customizable networks and applications, today announced OP Enterprise: its production-grade blockchain infrastructure offering. With OP Enterprise, OP Labs handles operations, security, and scaling so enterprises can focus on shipping products, […]
Philips is recognized for its market-leading innovation and comprehensive digital pathology ecosystem, driving global transformation in diagnostics and healthcare informatics SAN ANTONIO, Jan. 30, 2026 /PRNewswire/ — Frost & Sullivan is pleased to announce that Philips has been awarded the 2025 Global Enabling Technology Leadership Recognition in the Digital Pathology–Healthcare Informatics sector for its outstanding achievements in delivering […]
Pr Newswire
Skye Bioscience Highlights Attributes of its Peripherally-restricted CB1 Inhibitor Antibody at Keystone Obesity Conference
29
Jan
Jan
SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today presented a poster titled “Investigating the Efficacy of Nimacimab Alone or in Combination with Tirzepatide, and as a Maintenance Therapy Post Tirzepatide Discontinuation […]
Pr Newswire
Kymera Therapeutics Announces First Patient Dosed in BREADTH Phase 2b Asthma Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader
29
Jan
Jan
Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027 Data from the ongoing parallel BROADEN2 Phase 2b atopic dermatitis trial is expected to be reported by mid-2027 WATERTOWN, Mass., Jan. 29, 2026 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of […]
Pr Newswire
Fractyl Health Announces Compelling 6-Month Randomized REMAIN-1 Midpoint Data Showing Durable Weight Maintenance with Revita® After GLP-1 Discontinuation
29
Jan
Jan
Revita-treated patients experienced sustained weight maintenance, improved cardiometabolic profile, and reduced food cravings at 6 months compared with sham, with continued excellent safety and tolerability Patients with above median GLP-1-associated weight loss experienced ~ 70% less post-GLP-1 weight regain with Revita vs sham at 6 months Results support pivotal study design and further substantiate Revita’s […]
Pr Newswire
Terrapin Beer Co. Turns Up the Volume with a New Brand Identity Rooted in Music, Art and Craft Beer Culture
29
Jan
Jan
A modern visual evolution designed to amplify artistic storytelling across the brand portfolio ATHENS, Ga., Jan. 29, 2026 (GLOBE NEWSWIRE) — Terrapin Beer Co. (Terrapin), a craft beer brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), today announced a comprehensive brand refresh. The brand now features new visual interpretations and artist collaborations across […]
Pr Newswire
OMEICOS Therapeutics Announces Positive Phase 2 Study Outcome Demonstrating OMT-28’s Potential in Primary Mitochondrial Diseases (PMD)
29
Jan
Jan
Trial Results Support Transition into Late-Stage Development with Program Expected to be Phase 2b/3-ready in H2 2026 BERLIN, GERMANY, January 29, 2026 – OMEICOS, a clinical-stage biopharmaceutical company developing first-in-class small molecule therapeutics for mitochondrial and inflammatory disorders, announced the successful conclusion of its multi-centre, open-label Phase 2a PMD-OPTION Study evaluating its lead program OMT-28 […]